This is a working overview of synthetic peptide, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-06-20 and is reviewed periodically as new material appears.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.
The lyophilized peptide is a white to off-white powder that dissolves freely in water and in aqueous buffers near neutral pH. Because the molecule carries a net negative charge under physiological conditions, saline and phosphate solutions are the usual vehicles, while strongly acidic media are avoided. Stock solutions are commonly divided into small aliquots so that repeated freezing and thawing can be limited, since cycling may encourage aggregation. Solubility in organic solvents is poor and those solvents are seldom used as primary diluents.
Recommended storage for the dry powder is a freezer near minus twenty degrees Celsius, kept desiccated and away from light. Once dissolved, the peptide is less stable and is usually held at two to eight degrees Celsius for short intervals or frozen for longer storage. Stability studies focus on the acetylated terminus and the disulfide linkage because those features define the intact molecule. Common degradation routes include cysteine oxidation, deamidation of asparagine or glutamine side chains, and slow formation of higher-molecular-weight species.
Identity and purity are usually checked by reverse-phase high-performance liquid chromatography, which separates the intact chain from truncated products, together with mass spectrometry for confirmation of the expected mass. Peptide mapping after enzymatic digestion and amino acid analysis add sequence-level evidence. Release testing also covers water content, residual solvents, and counter-ions, all of which influence measured mass and stability. Related-peptide limits are commonly expressed as a percentage of total peak area, with individual unspecified impurities held below a lower threshold.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Peptide | 28 amino acid residues |
| Molecular weight | Approximately 3108 Da | Depends on acetylation state |
| N-terminal modification | Acetylated | Affects charge and stability |
| Natural source | Fragment of thymosin beta-4 | Cleaved in vivo |
| Sequence length | 28 residues | Synthetic form matches natural |
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
Biologically, the peptide is studied mainly in the context of immune cell development and regulation. It is produced in the thymus and in several other tissues, and it appears to influence the maturation and activity of T cells and other immune populations. Laboratory work describes effects on cytokine production, on the balance between T cell subsets, and on the function of dendritic cells. Much of this evidence comes from cell culture and animal models, so the extent to which the same pathways operate in humans remains an open question.
The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.
Thymosin alpha-1 is a short peptide of 28 amino acid residues first described in the 1970s as a component of thymic extracts. Its N-terminal residue carries an acetyl group, and the sequence is highly conserved across mammalian species. The peptide is not encoded as a standalone gene product; it is released by proteolytic cleavage from the N-terminus of prothymosin alpha, a larger acidic nuclear protein. That precursor relationship places it within a broader family of thymic and immune-associated peptides that have been studied for decades.
Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
Quantifying thymosin alpha-1 in a sample usually relies on reverse-phase high-performance liquid chromatography. The peptide lacks strong chromophores, so detection often occurs at 214 nm, where the peptide backbone absorbs. Mass spectrometry provides confirmatory identification and can detect sequence variants or truncations. Immunoassays have been used in biological matrices, but they may cross-react with related fragments. For purity assessment, chromatographic peak area gives the main component percentage, while mass accuracy verifies molecular identity.
The lyophilized peptide is generally stable for extended periods when kept cold and dry. Once dissolved, aqueous solutions are less stable; hydrolysis, oxidation, and aggregation can degrade the material. Storage at -20 °C or lower slows these processes. Repeated freeze-thaw cycles are best avoided because they can promote aggregation. The exact shelf life depends on formulation, pH, and concentration, so stability studies are typically performed for each specific product.
Quality control for thymosin alpha-1 focuses on identity, purity, and potency. Identity is confirmed by mass spectrometry and amino acid analysis, while purity is assessed by chromatography with limits on related substances and residual solvents. Potency assays may use cell-based immune readouts, but these are not standardized across laboratories. Regulatory status differs by jurisdiction; no product is approved in the United States for clinical use, whereas some other countries register injectable forms for specific indications.
It includes an intro song titled "Persona" rapped by group leader RM, who asks, "who am I?", and is confronted with various versions of himself with the words "persona", "shadow", and "ego", referring to Jung's theories. On 21 February 2020, the band released Map of the Soul: 7, which specifically focuses on Jung's "shadow" and "ego" theories. As part of the first phase of the band's comeback, "Interlude: Shadow", rapped by Suga and released on 10 January, addresses the shadows and the darkness that go hand-in-hand with the light and attention shone on celebrities. The next comeback trailer, "Outro: Ego", performed by J-Hope, ends with his declaration of self and ego as he appears within a colourful city "in which the artist's current image is projected". In 2019, Italian rapper Marracash released the album Persona, which features many Jungian themes. Jung appeared on the cover art of the 2008 single "Metanoia" by American psychedelic rock band MGMT. Composer John Zorn released his composition Liber Novus inspired by Jung's Red Book in 2010 on the Tzadik CD Dictée/Liber Novus. English rock musician Peter Gabriel's song The Rhythm of the Heat from his 1982 album, is directly based on Carl Jung's experiences during his time in Africa. The working title for the song was "Jung in Africa". Peruvian musician Daniela Lalita has cited Jung's archetype of the "Great Mother" as a major influence on her works Madre and Trececerotres.
==== Winter ==== Traditionally, the greatest varieties of kimchi were available during the winter. In preparation for the long winter months, many types of kimjang kimchi (김장 김치) were prepared in early winter and stored in the ground in large kimchi pots. Today, many city residents use modern kimchi refrigerators offering precise temperature controls to store kimjang kimchi. November and December are traditionally when people begin to make kimchi; women often gather together in each other's homes to help with winter kimchi preparations. "Baechu kimchi" is made with salted baechu filled with thin strips of radish, parsley, pine nuts, pears, chestnuts, shredded red pepper, manna lichen (Korean: 석이 버섯; RR: seogi beoseot), garlic, and ginger.
Beginning in late 1939, hundreds of thousands of Poles from the Soviet-occupied areas were deported and taken east. Of the upper-ranking military personnel and others deemed uncooperative or potentially harmful by the Soviets, about 22,000 were secretly executed by them at the Katyn massacre. In April 1943, the Soviet Union broke off deteriorating relations with the Polish government-in-exile after the German military announced the discovery of mass graves containing murdered Polish army officers. The Soviets claimed that the Poles committed a hostile act by requesting that the Red Cross investigate these reports. From 1941, the implementation of the Nazi Final Solution began, and the Holocaust in Poland proceeded with force. Warsaw was the scene of the Warsaw Ghetto Uprising in April–May 1943, triggered by the liquidation of the Warsaw Ghetto by German SS units. The elimination of Jewish ghettos in German-occupied Poland took place in many cities. As the Jewish people were being removed to be exterminated, uprisings were waged against impossible odds by the Jewish Combat Organization and other desperate Jewish insurgents.
Sources: en.wikipedia.org
=== Occurrence in fungi === Many fungi produce hydrogen cyanide from glycine. These include representatives of the genera funnel mushrooms (Clitocybe), dwindlers (Marasmius), stem porcini (Polyporus), and Ritterlinge (Tricholoma). The epurpurins are a group of yellow phenolic pigments, each bearing two nitrile groups, occurring in Emericella purpurea. Diatretin II occurs in Fleshy Fungus (Clitocybe diatreta) and in the purple reddish bolete. In the clove dwarf mushroom, the cyanohydrin of glyoxylic acid is present; it is formed from two glycine molecules and releases hydrocyanic acid upon tissue damage.
Absorption bases, e.g., beeswax and wool fat Emulsifying bases, e.g., cetrimide and emulsifying wax Hydrocarbon bases, e.g., ceresine, microcrystalline wax, hard paraffin, and soft paraffin Vegetable oil bases, e.g., almond oil, coconut oil, olive oil, peanut oil, and sesame oil Water-soluble bases, e.g., macrogols 200, 300, 400 The water number of an ointment is the maximum quantity of water that 100g of a base can contain at 20 °C. Ointments are formulated using hydrophobic, hydrophilic, or water-emulsifying bases to provide preparations that are immiscible, miscible, or emulsifiable with skin secretions. They can also be derived from hydrocarbon (fatty), absorption, water-removable, or water-soluble bases. Evaluation of ointments:
Scarification involves scratching, etching, burning/branding, or superficially cutting designs, pictures, or words into the skin as a permanent body modification or body art. The body modification can take roughly 6–12 months to heal. In the process of body scarification, scars are purposely formed by cutting or branding the skin by various methods (sometimes using further sequential aggravating wound-healing methods at timed intervals, like irritation). Scarification is sometimes called cicatrization.
Sources: en.wikipedia.org
=== Structure === Tetrahymanol is a pentacyclic triterpenoid molecule. The triterpenoids are a class of molecules found in both bacteria and eukaryotes, which largely make hopanols and sterols, respectively. The structures of these three classes of molecules are shown below. Cholesterol and diploptene are used as model sterol and hopanol structures, respectively. While diploptene and tetrahymanol broadly have similar structures, the fifth ring on tetrahymanol is a cyclohexane rather than a cyclopentane. All three of these molecular classes have structures that lend themselves to membrane rigidity and other, still unknown, physiological functions. The similarity of tetrahymanol to the other classes of triterpenoid molecules allows it to substitute for hopanols and sterols in cell membranes. The tetrahymanol structure can have multiple stereoisomers. Its chiral methyl and hydrogen substituents can switch enantiomers during diagenesis, giving the molecule different properties with each isomer. When gammacerane, the diagenetic product of tetrahymanol, is analyzed, its isomers can be separated and provide information about the origin and thermal maturity of the sample.
Radar equipment is used at airports, in airplanes, at missile sites, on tanks, and on ships. The radar technology commonly used in the 20th century produced X-rays as a technically unavoidable by-product in the high-voltage electronics of the equipment. In the 1960s and 1970s, German soldiers and technicians were largely unaware of the dangers, as were those in the GDR's National People's Army. The problem had been known internationally since the 1950s, and to the German Armed Forces since at least 1958. However, no radiation protection measures were taken, such as the wearing of lead aprons. Until about the mid-1980s, radiation shielding was inadequate, especially for pulse switch tubes. Particularly affected were maintenance technicians (radar mechanics) who were exposed to the X-ray generating parts for hours without any protection. The permissible annual limit value could be exceeded after just 3 minutes. It was not until 1976 that warning notices were put up and protective measures taken in the German Navy, and not until the early 1980s in general. As late as the 1990s, the German Armed Forces denied any connection between radar equipment and cancer or genetic damage. The number of victims amounted to several thousand. The connection was later acknowledged by the German Armed Forces and in many cases a supplementary pension was paid. In 2012, a foundation was set up to provide unbureaucratic compensation for the victims.
=== Morphology === "Candidatus Magnetoglobus multicellularis" is an obligately multicellular bacteria without a unicellular stage in its lifecycle. It typically consists of 10–40 bacterial cells in an organised spherical structure surrounding an acellular compartment. The entire organism has a diameter of approximately 3 to 12 micrometres. Individual cells are elongated into a pyramidal shape, with the narrow apex facing the acellular compartment in the centre. The outward-facing surface of each cell houses numerous flagella. The cells are all tightly joined by highly specialised intercellular junctions, similar to those found in eukaryotic multicellular organisms. The exterior of the organism features a cellulose matrix that plays a role in cell adhesion and structural integrity.
Sources: en.wikipedia.org
It corresponds to the first 28 amino acids of thymosin beta-4, a larger protein found in many tissues. The fragment is acetylated at its N-terminus and is produced synthetically for research and pharmaceutical use. Synthetic and natural forms share the same sequence.
It is usually described as an immunomodulatory peptide rather than a classical hormone. It does not travel to a single distant organ in the manner of an endocrine hormone. Classification varies across sources, and some texts group it with thymic peptides generally.
The broad outline involves immune cell activation, but the specific molecular steps remain under investigation. Different studies report effects on dendritic cells, T cells, and natural killer cells. No single receptor has been confirmed as the sole mediator.
Reconstituted solutions are typically kept refrigerated at two to eight degrees Celsius when used within a short window, or frozen in aliquots for longer periods. Repeated freeze-thaw cycles are avoided because they can reduce recovery of intact peptide.